Search
Powered By HealthLine
Special Offers
TV Specials
 Learn about an Effective Alzheimer's Medication
 Bipolar Education Health Center
 Osteoarthritis of the Knee Solution Center
 Heartburn Education Center
 Breast Cancer Health Center
 Crohn's Disease Health Center
 Schizophrenia Education Center
Top Features
 Depression
 Schizophrenia
 Breast Cancer
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Aspirin May Cut Pregnancy Complication Risk

Daily use lowers odds for the dangerous spike in blood pressure called preeclampsia

By Steven Reinberg
HealthDay Reporter


Related Encyclopedia
 border=
AIDS and HIV Infection
Alzheimer's Disease
Amenorrhea
Amniocentesis
More...

Related Healthscout Videos
 border=
Preventing Breast Cancer
Tracking Breast Cancer Treatment
Howard: The Helping Hand for Stroke Survivors
Easier Radiation for Breast Cancer
More...

Related Animations
 border=
Alzheimer's Disease Video Animation
Angioplasty
Animation: What is Hypertension?
Breast Reduction
More...

Related Drug Information
 border=
Accupril
Actonel
Altace
Avapro
More...

Related News Articles
 border=
Drug-Coated Stents Still Spark Debate
Health Tip: Coping With Alzheimer's
Group B Strep Down Among Newborns, Up Among Adults
Mood Disorders Put Breast Cancer Patients at Risk for PTSD
More...

THURSDAY, May 17 (HealthDay News) -- Women at high risk for the pregnancy complication preeclampsia can lower their odds by 10 percent by taking daily aspirin, a new study suggests.

Preeclampsia is a potentially fatal obstetric complication that can lead to sudden high blood pressure and irregular blood flow. This can activate platelets and the clotting system, which in turn slows blood flow.

Text Continues Below



The use of aspirin may help counter this effect, according to a report in the May 16 online issue of The Lancet.

"Preeclampsia complicates between about 2 and 8 percent of all pregnancies, and is associated with approximately 10 to 15 percent of the half-million maternal deaths [worldwide] that occur each year," said lead researcher Lisa Askie, a research fellow in the School of Public Health at the University of Sydney, Australia.

Although the benefits of antiplatelet therapy such as daily aspirin are modest, they are important if given to women at risk of preeclampsia, Askie said. "They could potentially result in many thousands less women who experience a bad pregnancy outcome. Hence, particularly for women at high risk of preeclampsia, a more widespread use of antiplatelet agents may be worthwhile," she said.

In the study, Askie and colleagues in the Perinatal Antiplatelet Review of International Studies (PARIS) group looked at the results of 31 preeclampsia prevention trials that included almost 33,000 women and their babies. Women who took aspirin in these trials typically took between 50 milligrams to 150 milligrams of the drug per day.

The researchers found the risks of developing preeclampsia dropped 10 percent among women taking aspirin or other antiplatelet medications. In addition, these women also had a lower risk of delivering before 34 weeks and of having other pregnancy problems.

Page:  1 | 2 | Next >>

Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 5/17/2007

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





New Features

New ADHD Site!

SOURCES: Lisa Askie, Ph.D., M.P.H., research fellow, School of Public Health, University of Sydney, Australia; James Roberts, M.D., director, Magee-Womens Research Institute, University of Pittsburgh; May 16, 2007, The Lancet online


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map